Literature DB >> 1670676

Peritonitis due to vancomycin-resistant Staphylococcus epidermidis.

D Sanyal, A P Johnson, R C George, B D Cookson, A J Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1670676     DOI： 10.1016/0140-6736(91)93375-j

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.

Authors:  A Giacometti; O Cirioni; R Ghiselli; L Goffi; C Viticchi; F Mocchegiani; A Riva; F Orlando; V Saba; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.

Authors:  K Sieradzki; R B Roberts; D Serur; J Hargrave; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  B Fantin; J Pierre; N Castéla-Papin; L Saint-Julien; H Drugeon; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis.

Authors:  Bret R Sellman; Alan P Howell; Cari Kelly-Boyd; Steve M Baker
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.

Authors:  W M Milewski; S Boyle-Vavra; B Moreira; C C Ebert; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 7.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.

Authors:  B Fantin; R Leclercq; Y Merlé; L Saint-Julien; C Veyrat; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

9.  R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro.

Authors:  Zheng Hou; Fei Da; Baohui Liu; Xiaoyan Xue; Xiuli Xu; Ying Zhou; Mingkai Li; Zhi Li; Xue Ma; Jingru Meng; Min Jia; Yukun Wang; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

10.  Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.

Authors:  Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Alessandra Riva; Maria Simona Del Prete; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.